Catalyst Wire Dossier Catalyst Wire Dossier

Autologous CAR T cells targeting B7-H3

B7-H3-targeted autologous CAR T cells · UNC Lineberger Comprehensive Cancer Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous CAR T cells targeting B7-H3, covering 2025-12-22 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian [Phase 1]

See pricing